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ABSTRACT
Modeling Action Potential Propagation During Hypertrophic Cardiomyopathy Through a ThreeDimensional Computational Model
Julia Kelley

Hypertrophic cardiomyopathy (HCM) is the most common monogenic disorder and the
leading cause of sudden arrhythmic death in children and young adults. It is typically
asymptomatic and first manifests itself during cardiac arrest, making it a challenge to diagnose in
advance. Computational models can explore and reveal underlying molecular mechanisms in
cardiac electrophysiology by allowing researchers to alter various parameters such as tissue size
or ionic current amplitudes. The goal of this thesis is to develop a computational model in
MATLAB and to determine if this model can accurately indicate cases of hypertrophic
cardiomyopathy. This goal is achieved by combining a three-dimensional network of the bidomain
model with the Beeler-Reuter model and then by manually varying the thickness of that tissue
and recording the resulting membrane potential with respect to time. The results of this analysis
demonstrated that the developed model is able to depict variations in tissue thickness through the
difference in membrane potential recordings. A one-way ANOVA analysis confirmed that the
membrane potential recordings of the different thicknesses were significantly different from one
another. This study assumed continuum behavior, which may not be indicative of diseased tissue.
In the future, such a model might be validated through in vitro experiments that measure electrical
activity in hypertrophied cardiac tissue. This model may be useful in future applications to study
the ionic mechanisms related to hypertrophic cardiomyopathy or other related cardiac diseases.
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Chapter 1
INTRODUCTION

The human heart is the sole organ that maintains the proper function of all other organs
within the body. As the heart pumps blood throughout the body, it enables us to breathe, think,
move, and empowers us in several other ways that bring quality to our lives. This quality of life is
impeded at the onset of a cardiac disease, such as hypertrophic cardiomyopathy (HCM). As the
leading cause of sudden arrhythmic death for children and young adults, HCM is often
asymptomatic and first presents itself during ventricular tachyarrhythmia, making it impossible to
diagnose before it becomes fatal. The cardiac action potential, an electrical impulse that
disperses throughout the heart via rapid changes in the membrane potential of cardiomyocytes, is
known to showcase evidence of HCM in its prolonged repolarization period. Computational
modeling allows us to model such electrical activity within the heart. The goal of this thesis is to
determine whether a three-dimensional computational model of cardiac tissue can mimic
hypertrophic cardiomyopathy by varying the tissue thickness to observe changes in the shape of
the action potential as it propagates through the tissue.

1.1

Motivation

Hypertrophic cardiomyopathy (HCM) is a disease that affects ventricular functioning
through the increase in thickness of the ventricular wall. It is the most common monogenic
cardiac disorder and is the main cause of sudden cardiac death in children and young adults [1].
Its reported prevalence is 1 in 500 adults in the U.S. and typically those who are affected are
asymptomatic. It can be characterized by the unexplained thickening of the left ventricle.
Mechanical stretch, caused by volume or pressure overload, leads the heart to send out stress
signals which activate a hypertrophic response to compensate for wall stress. This in turn leads to
cardiac remodeling [2]. The hypertrophic remodeling of the heart has three stages: developing
hypertrophy, compensatory hypertrophy, and overt heart failure. In developing hypertrophy, the
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load placed on the heart begins to exceed its output. In compensatory hypertrophy, the workloadto-mass ratio becomes normalized, and a resting cardiac output is maintained. Hypertrophy that
occurs as a consequence of pressure overload is termed “compensatory” on the premise that it
facilitates ejection performance by normalizing systolic wall stress [3]. In overt heart failure,
ventricular dilation occurs and there are substantial declines in cardiac output, often leading to
sudden cardiac death [3]. In fact, the first known manifestation of hypertrophic cardiomyopathy is
arrhythmic sudden death caused by ventricular tachyarrhythmias [1]. HCM is challenging to
diagnose since it presents as asymptomatic and doesn’t become apparent until those who are
affected by it are in cardiac arrest.
The underlying electrophysiological mechanisms that cause hypertrophic cardiomyopathy
are still unclear. Previous studies have investigated the ionic mechanisms driving repolarization
abnormalities in human HCM cardiomyocytes. One study used experimental ionic current, action
potential, and calcium-transient recordings to construct populations of human non-diseased and
HCM action potential (AP) models which were then run through simulations of several degrees of
selective and combined current block [1]. Another study used human embryonic stem-cell derived
cardiomyocytes (hESC-CMs) subjected to mechanical stretch to investigate whether this type of
in vitro model could reveal molecular mechanisms of cardiac hypertrophy and identify potential
targets in the process [2]. While this model was able to replicate all specific hypertrophic
hallmarks, human in vitro models are limited by the amount of available patient-derived
cardiomyocytes. Likewise, animal models do not always accurately represent the mechanisms
responsible for hypertrophic cardiomyopathy in humans due to inter-species differences.
Understanding the underlying electrophysiological mechanisms of hypertrophic
cardiomyopathy is critical for advancing interventional therapeutics. Adequate research models
are needed for the studies of root mechanisms of HCM at the molecular level. This thesis
proposes combining the bidomain model with an ionic current model to create a piece of cardiac
tissue for the purpose of analyzing the effects of HCM. Using a computational model to
investigate how a cardiac action potential changes due to hypertrophic cardiomyopathy will be
useful as it allows the researcher to vary the model parameters and observe their consequent
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effects on the tissue. By taking control of the parameters that influence the cardiac action
potential, one can gain insight into the root mechanisms that alter the shape of the action
potential at the molecular level. Computational models may help to improve future interventional
methods by providing a non-invasive, efficient method for observing changes in the action
potential of cardiomyocytes that are seeded in cellular chemistry.

1.2

Previous Work

There is little information published on using in silico, or computational, models to
observe the theoretical behavior of hypertrophic cardiomyopathy. A distinct divide exists in the
published literature between studies that examine ionic mechanisms of hypertrophic
cardiomyopathy through in vitro experiments and studies that investigate the general
electrophysiological behavior of non-diseased cardiac tissue through in silico models. Previous
studies [1, 2, 4] have demonstrated that ionic mechanisms significantly contribute to rhythm
abnormalities. Repolarization abnormalities are particularly prominent in the case of hypertrophic
cardiomyopathy [1]. Specifically, phases two and three of the action potential are prolonged. This
consequence was found to be driven by L-type 𝐶𝑎2+current reactivation [1]. Molecular
mechanisms of HCM have been revealed through in vitro experiments that were additionally able
to uncover biomarkers that indicated the presence of HCM [2]. Such biomarkers have not been
thoroughly researched but could be a key player in developing pharmacological treatments for
HCM. There have been several studies [4, 5, 6, 7] that utilized in silico modeling to look at
electrical activity of the heart through a coupling of the bidomain model with an ionic current
model. Multiple ionic current models have been used in the literature due to their variations in
complexity. However, these studies have noted that the combination of the bidomain model with a
complex ionic current model makes the simulations computationally expensive and often require
great computing power [4, 7]. Another limitation of in silico models is that they often assume
continuum behavior, which may not be accurate when modeling diseased tissue. Computational
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modeling studies seek to characterize and predict the biophysical phenomena underlying
electrical excitation and conduction [5].
A study by Passini et al. [1] used experimental ionic current, action potential, and
calcium-transient recordings to construct populations of human non-diseased and HCM AP
models which were subjected to simulations of several degrees of selective and combined inward
current block. Passini et al. found that the simulated HCM cardiomyocytes exhibited prolonged
action potentials and calcium-transient currents, along with diastolic calcium overload and a
decreased calcium-transient amplitude. HCM is characterized in part by repolarization
abnormalities, and this study found that while it was driven by L-type 𝐶𝑎2+ current reactivation,
multichannel block increased efficacy in normalizing the repolarization as well as action potential
biomarkers. While there are only a few studies that delve into researching HCM biomarkers, the
ones that have researched them serve as great potential for paving the way towards treatment. A
study by Ovchinnikova et al. [2] used human embryonic stem-cell derived cardiomyocytes (hESCCMs) that were subjected to mechanical stretch to investigate whether this type of in vitro model
could reveal molecular mechanisms of cardiac hypertrophy and identify potential biomarkers in
the process. After subjected the hESC-CMs to cyclic mechanical stress, Ovchinnikova et al. used
an RNA-sequence approach to determine the global gene expression changes involved in the
hypertrophic response to stress. Genetic mutations are often a contributing factor when it comes
to hypertrophic cardiomyopathy [8]. This study demonstrated the successful use of hESC-CMs in
predicting molecular mechanisms of cardiac hypertrophy and identifying potential targets in the
process. Ovchinnikova et al. intended to pave a way towards bridging the gap between in vitro
and pharmacological approaches to understanding what causes cardiac hypertrophy.
Previous computational-based studies have been used to analyze how an electrical
impulse propagates through healthy cardiac tissue by varying ionic parameters. In a study by
Ibrahim et al. [4], a model composed of a bidomain coupled with the Fitzhugh-Nagumo model
was implemented to study the effects of varying ionic current model parameters on the
propagation of electrical waves through cardiac tissue. The model was time-discretized using the
explicit forward Euler’s method and space-discretized using a two-dimensional network to obtain
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linearized equations. This study discovered that only a decrease in the excitation rate constants
had an impact on the cardiac wave propagation. A key takeaway from Ibrahim’s study is that the
simulation of bidomain equations may be more fruitful if one were to use a three-dimensional
network with other ionic current models. A study by Bantle [7] took the three-dimensional
bidomain network approach coupled with the Ten Tusscher model [36]. Bantle, however, was
unable to recreate a full action potential of a ventricular myocyte. The limitation in this result was
thought to have been seeded in the coupling of neighbor cells, although it is a less accurate
model when the neighboring cells are decoupled. Akin to the study by Ibrahim et al., a study by
Tanyous [6] used two-dimensional bidomain modeling coupled with the Fitzhugh-Nagumo model,
but instead focused on mapping electrical propagation in the cardiac sinoatrial node. The
computational model was used to validate experimental treatments within the same study.
Tanyous discovered that there were preferred paths of wave propagation and an uneven
distribution of the velocity of wave propagation, and therefore of tissue conductance, from the
sinoatrial node to its periphery. A summary of the prior work discussed in Section 1.2 is described
in Table 1.1.

Table 1.1 Summary of Prior Work
Passini et al. [1]

Studied mechanisms of pro-arrhythmic abnormalities in ventricular
repolarization in cases of hypertrophic cardiomyopathy

Ovchinnikova et al.
[2]

Modeled cardiac hypertrophy by subjecting hESC-CMs to
mechanical stretch to mimic molecular mechanisms and uncover
biomarkers

Chang [5]

Used theoretical and experimental models to affect action potential
propagation in cardiac tissue to better understand the electrogram

Ibrahim et al. [4]

Modeled cardiac electrical activity using bidomain and FitzhughNagumo models and varying ionic parameters

Bantle [7]

Modeled the electrical activity of a wedge of ventricular heart tissue
by coupling the bidomain and Ten Tusscher models

Tanyous [6]

Mapped electrical propagation in the sinoatrial node using an insilico model to validate an experimental model
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1.3

Outline

It is important to bridge the gap between in vitro studies on ionic mechanisms of HCM
and computational studies on general cardiac electrophysiology. Assessing cases of HCM
through in silico studies will allow researchers to reach conclusions on the molecular activity of
diseased cardiac tissue by altering various ionic mechanisms to pinpoint root causes and
targeted areas of HCM. The objective of this thesis is to determine whether a three-dimensional
computational model of cardiac tissue can mimic hypertrophic cardiomyopathy by varying the
tissue thickness to observe changes in the shape of the action potential as it propagates through
the tissue. Specifically, the analysis of the change in membrane potential in an action potential as
it propagates through tissues of varying thickness will be useful to understand how a change in
cardiac tissue thickness will impact the heart’s ability to transmit an electrical impulse and
therefore how likely it is for the heart to experience HCM. A three-dimensional computational
model is not limited in the way that a clinical, animal, or in vitro study would be since it allows for
the flexibility of parameter alteration and can accurately represent the mechanisms responsible
for HCM in humans.
The organization of the paper is as follows: first, the background of the human
cardiovascular system, the conduction of the electrical impulse of the heart, the cardiac action
potential, membrane potential, hypertrophic cardiomyopathy, ventricular myocyte remodeling, and
modeling cardiac tissue will be described; mathematical descriptions and the methods for the
setup of the Beeler-Reuter and bidomain models in MATLAB will be outlined; the results of the
analysis will be presented, validated, and statistically analyzed; and the results will be discussed
as they pertain to the goal of this thesis. A statistical analysis will be performed in JMP, a suite of
computer programs for statistical analysis that was developed by John Sall in the 1980’s (JMP
stands for “John’s Macintosh Project”), to determine if a significant difference exists between the
action potentials that stem from tissues with different thicknesses. The model will be validated by
first visually comparing the output of the algorithm for membrane potential of a single ventricular
myocyte, as described by the Beeler-Reuter model, to that which is found in the literature [9].
Once that algorithm has been validated, the active three-dimensional model will be compared to a
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passive three-dimensional model to determine if the injected stimulus current has a noticeable
effect. The accuracy of the electrical components’ representation of the physiological components
will be validated by describing the role of gap junctions, how they are affected during hypertrophic
cardiomyopathy, and how their electrical equivalents predispose a prolonged action potential
during cases of hypertrophy. Clinical data such as human cardiac action potential dynamics are
scarce or limited in the literature by practical or ethical concerns [10]. Thus, such data was unable
to be obtained for validation purposes in this paper.
This study seeks to answer whether the presented three-dimensional computational
model can depict changes in the shape of an action potential moving through cardiac tissue of
varying thickness. The purpose of this investigation is to see if the resulting action potentials will
mimic those seen in cases of hypertrophic cardiomyopathy. The shape of the action potential is
hypothesized to elongate in phases two and three with an increase in tissue thickness.
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Chapter 2
BACKGROUND

2.1

The Human Cardiovascular System

The function of the heart is to pump oxygenated blood to all tissues within the body and
to pump deoxygenated blood to the lungs. The heart consists of four chambers: the left and right
atria and the left and right ventricles. The upper chambers, or the atria, receive blood coming
from the systemic and pulmonary systems. They push blood into the lower chambers, or the
ventricles, to be ejected to the lungs and the rest of the body. The atria are separated by the
interatrial septum and the ventricles are separated by the interventricular septum. The septum
between the atria and ventricles is known as the atrioventricular septum, marked by four valves
that allow blood to flow from the atria to the ventricles [11]. Each of the major pumping chambers
of the heart ejects approximately 70 mL of blood per contraction in a resting adult. The shape and
size of the heart can be thought of as an inverted pear. It sits within the thoracic cavity and is
medially located between the lungs. The superior and inferior vena cavae, the aorta, and the
pulmonary trunk are located on the superior surface of the heart, known as the base. The inferior
surface of the heart, known as the apex, lies to the left of the sternum. Figure 2.1 depicts the
structural arrangement of the components described above within the heart.
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Figure 2.1. The anatomical structure of the human heart [11].
The size of the average adult’s heart can be compared to a clenched fist. However, the
heart of a well-trained athlete can be considerably larger than normal. Similar to skeletal muscle,
cardiac muscle increases in protein myofilaments as a result of exercise, increasing the size of
individual cells.This is known as physiological hypertrophy. The heart remodels itself in response
to an increase in exercise to pump blood more effectively throughout the body. In the average
adult heart (whether they are physically active or not), the left ventricle is considerably larger than
the right ventricle. It is thicker and more developed so that it can overcome high resistance and
develop a large amount of pressure required to pump blood into the long systemic circuit. The
right ventricle does not require as much pressure to overcome resistance because the pulmonary
circuit is much shorter than the systemic circuit and therefore has much less resistance [11].
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Figure 2.2. Differences in ventricular muscle thickness of a healthy human heart [11].

There are two distinct but linked circuits within the cardiovascular system: the pulmonary
and systemic systems. The pulmonary circuit transports blood to and from the lungs, where it
picks up oxygen from inhalation and delivers carbon dioxide for exhalation. The systemic circuit
transports oxygenated blood to almost all tissues within the body (excluding the lungs) and
returns deoxygenated blood and carbon dioxide to the heart to be sent to the lungs for the carbon
dioxide to be exhaled and for the deoxygenated blood to be reoxygenated. Highly oxygenated
blood returns to the heart through the pulmonary veins. They conduct blood into the left atrium,
which pumps blood into the left ventricle, sending blood out to the systemic circuit. Deoxygenated
blood flows into the superior and inferior vena cavae, returning blood to the right atrium. The right
atrium then pumps blood into the right ventricle which sends blood into the pulmonary circuit to
expel waste and to be reoxygenated [11].
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Figure 2.3. The dual system of human blood circulation: the systemic and pulmonary circuits
[11].
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2.2

Conduction System

The conduction system of the heart is arranged to allow for spontaneous firing and rapid
transmission of an electrical impulse throughout the entire heart. It controls the timing of the
electrical transfer between the atria and the ventricles, allowing for optimum hemodynamic
performance [12]. Two key structural components of cardiac tissue that enable rapid,
synchronous impulse transmission are intercalated disks and gap junctions. Intercalated disks
mechanically connect adjacent cardiomyocytes while gap junctions electrically connect them.
Gap junctions are structured as rings made up of proteins called connexons. They allow ions,
nutrients, metabolites, and small proteins to pass. But most importantly, gap junctions allow the
transfer of electrical impulses from one myocyte to the next.
The primary electrical components of the conduction system include the sinoatrial (SA)
node, the atrioventricular (AV) node, the bundle of His, the left and right bundle branches, and the
Purkinje fibers. The sinoatrial node is found at the top of the right atrium (near the entrance to the
superior vena cava); the atrioventricular node is found at the interatrial septum; the bundle of His
extends down from the atrioventricular node into the septum; the bundle branches disperse into
their respective ventricles; and the Purkinje fibers are extensions of each set of bundle branches
into the ventricular walls [12].
Pacemaker cells in the sinoatrial node spontaneously depolarize, dispersing an electrical
impulse throughout both atria allowing them to contract simultaneously. The depolarization
spreads from the right atrium to the left atrium through Bachmann’s bundle [13]. The impulse then
travels from the sinoatrial node to the atrioventricular node through the internodal fibers. Once the
electrical impulse reaches the atrioventricular node, there is a slight delay in transmission to allow
the ventricles to fill. Cells in the AV node conduct slower than those in the SA node to allow this
delay in the electrical impulse transmission from the atria to the ventricles [12].
Once the ventricles are sufficiently filled, the electrical impulse rapidly travels down the
bundle of His into the left and right bundle branches and finally to the Purkinje fibers located in
the walls of the ventricles. The rapid conduction velocity of the latter half of the conduction system
can be attributed to larger cell sizes, a unique distribution of gap junctions along the cell borders,
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and an encapsulating fibrous sheath surrounding the conduction network [12]. Figure 2.4 portrays
the conduction system embedded within the structure of the heart.

Figure 2.4. Electrical conduction system of the human heart [14].

2.3

Cardiac Action Potential

An action potential is the transmission of an electrical impulse which is the result of a
rapid sequence of changes in the membrane potential. In an adult mammalian heart, the cardiac
action potential travels as an electrical impulse through the heart’s conduction system as a
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means for maintaining the regular contractions of the heart to maintain perfusion to vital organs
within the body [13]. During each heartbeat, the signal to contract reaches cardiac muscle cells in
the form of an electrical impulse. At the cellular level, this electrical impulse causes a rapid
release of calcium ions from intracellular stores to activate contraction in the sarcomere. This
sequence of events from electrical excitation to force production is known as cardiac excitationcontraction coupling. Ion channels and their accessory proteins at the cell membrane are
responsible for detecting and propagating the transient changes in the membrane potential that
initiate contraction. Electrical changes in the membrane potential open L-type 𝐶𝑎2+ channels,
triggering 𝐶𝑎2+ release from the sarcoplasmic reticulum in a process known as 𝐶𝑎2+-induced
release. Membrane-bound proteins in the sarcoplasmic reticulum are responsible for 𝐶𝑎2+
reuptake from the cytosol, which lowers 𝐶𝑎2+ and causes its contraction to end [15]. It could be
perceived that the entire process of force generation by the myofilaments forms part of the
excitation-contraction coupling. This sequence of events proves that an understanding of the
relationship between excitation and the force produced by contraction depends critically on the
properties of myofilaments.

Figure 2.5. Excitation-contraction coupling in cardiac muscle [16].
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The cardiac action potential differs from those that propagate through the nervous system
for two main reasons: automaticity and a delayed plateau phase. Automaticity is only found in
pacemaker cells within the heart because they have the intrinsic ability to depolarize rhythmically
and initiate an action potential. The delayed plateau phase, while only found in the action
potentials of cardiomyocytes, serves to allow enough time for muscle contraction during Phase 2
of the action potential.
There are a total of five types of cells that make up the adult mammalian heart:
cardiomyocytes cells, pacemaker cells, fibroblasts, endothelial cells, and perivascular cells.
Cardiomyocytes and pacemaker cells are the most abundant and the most crucial for propagating
action potentials. Cardiomyocyte cells and pacemaker cells elicit different action potential
waveforms. In this paper, the cardiomyocyte cell action potential is highlighted and discussed as
it pertains to the Beeler-Reuter model of ventricular cardiomyocytes.
There are five phases to the cardiomyocyte action potential. A depiction of these five
phases can be seen in Figure 2.5. They are structured in the sequence as follows:
•

Phase 0: During this phase, rapid depolarization takes place. Voltage-gated sodium
channels open causing an influx of sodium ions which brings the membrane potential to
+50 mV. This accounts for the steep upstroke in the shape of the action potential

•

Phase 1: During this phase, there is a slight drop in the membrane electrochemical
potential. The previously open sodium channels inactivate while potassium channels
activate a transient outward potassium current

•

Phase 2: This is considered as the ‘plateau’ phase. There is a calcium ion influx,
balancing the potassium ion efflux – this creates a plateau around +50 mV.
Subsequently, the calcium ion influx stimulates the calcium release from the
sarcoplasmic reticulum, initiating muscle contraction.

•

Phase 3: Repolarization takes place. Calcium ion channels close and there is a continued
potassium ion efflux through the opening of rapid delayed rectifier potassium channels.
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•

Phase 4: The repolarizing current from Phase 3 brings the membrane potential back to its
initial resting value and is maintained by a potassium current.

Figure 2.6. Phases of the cardiac action potential [15].

2.4

Membrane Potential

Membrane potential is a phenomenon that facilitates the propagation of an action
potential in excitable tissues [16]. It will always remain in either a resting or active state. The
resting membrane potential is maintained by the cells’ ion channels [16]. In the resting state, the
cell membrane maintains an equilibrium potential (which can be determined by the Nernst
equation). The resting state of the cell membrane is determined primarily by two factors: the
differences in ion concentration of both the intracellular and extracellular fluids, and the relative
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permeabilities of the plasma membrane to different ion species. The cell membrane is a
lipoprotein complex (7-15 nm thick), and during the resting state is only slightly permeable to
sodium ions and freely permeable to potassium ions. Essentially, the cell membrane can be
described as a leaky capacitor. The potassium concentration difference between the inside and
outside of the cell creates a diffusion gradient for potassium ions to flow outwards, making the cell
interior more negative. However, the electric field supported by the membrane at rest tends to
inhibit the outward flow of positively charged ions (e.g., K+) as well as the inward flow of negative
ions (e.g., Cl-). This makes the diffusional and electrical forces acting across the membrane
opposed to each other, creating an equilibrium potential [17]. The resting membrane potential
becomes active when an adequate stimulus influences the ionic concentration in the cell, initiating
a depolarization.
Emerging evidence shows that a dynamic membrane potential is essential for many other
processes including cell cycle, cell volume control, proliferation, and muscle contraction (even in
the absence of an action potential). The maintenance of cell volume in particular is essential for
cell survival, and membrane potential is a key regulator of this in cardiomyocytes. The membrane
potential feeds into the cell volume control mechanism by changing the driving force for ionic
current fluxes [16]. Since changes in cell volume are accompanied by ionic current fluxes, the
change in cell volume may influence membrane excitability, contraction, and cellular homeostasis
[18]. While it was formerly believed that cardiac tissue hypertrophy was the result of
cardiomyocyte proliferation, recent studies have found that adult cardiomyocytes grow through
hypertrophy (increase in cell size) instead of hyperplasia (increase in cell number). Cardiac cells
proliferate as embryos, but that proliferation turns into cell hypertrophy as the cardiac cells mature
[19]. Since it is known that membrane potential is a key regulator of cardiomyocyte cell volume, it
is understandable why hypertrophic cardiomyopathy alters the shape of the action potential as it
propagates through the cell membrane.

17

Figure 2.7. Fluctuation in membrane potential in cardiac cells during an action potential [11].

2.5

Hypertrophic Cardiomyopathy

Unexplained hypertrophic cardiomyopathy (HCM) is present in one out of every 500
adults in the United States [15]. HCM is the default diagnosis for patients presenting with left
ventricular wall thickness, but without causative factors such as hypertension. It can be most
simply defined as the increase in cardiac tissue size to compensate for a reduction in cardiac
function. This compensation activates the sympathetic nervous system, the renin-angiotensinaldosterone systems, and other neurohormonal mechanisms. The activation alters signal
transduction, leading to a change in gene expression that produces myocyte hypertrophy [20]. In
the majority of cases, HCM can be traced to genetic factors. Genetic linkage studies, the first
appearing two decades ago, have identified mutations to sarcomeres as the primary cause. The
inherited form of the disease, familial hypertrophic cardiomyopathy (FHC), is associated with left
ventricular wall thickness, myocardial fibrosis, myocyte disarray, and increased risk of sudden
cardiac death. The implicit hypothesis in current FHC research is that hypertrophy, regardless of
its advanced form, is the result of altered acute function at the level of the cardiac sarcomere [15].
HCM is often asymptomatic and first presents itself during instances of cardiac failure, particularly
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ventricular tachyarrhythmias. It is the most common monogenic disorder and is the main source
of sudden cardiac death in children and young adults [1]. The intrinsic cardiac and peripheral
responses to myocardial failure adversely alter the electrophysiology of the heart, predisposing
patients with heart failure to an increase in arrhythmic death [20]. No cure exists for the condition,
and treatments to alleviate the symptoms are limited.

Figure 2.8. (A) A normal thin myocardial section stained with H&E. (B) A low magnification (×4)
H&E-stained thin myocardial section from a patient heart with HCM [8].

There is evidence in the literature [1, 20, 21] that a consequence of hypertrophic
cardiomyopathy is a prolonged repolarization period in the action potential of cardiomyocytes as
well as a prolonged presence of calcium transient current. Passini et al. found that L-type calcium
current reactivation contributed to repolarization abnormalities in cardiomyocytes. Coltart et al.
described how previous investigations into prolonged repolarization of cardiomyocytes attributed
that abnormality to reasons such as massive, short irregular fibers with abnormal nuclei, a subset
of other cardiac diseases, and having excessive noradrenaline deposits in the diseased muscle.
However, this study found that hypocalcemia was a contributing factor to prolonged repolarization
periods in cardiomyocytes. Tomaselli et al. discussed the implications of functional alterations in
the depolarizing and repolarizing currents as the general reason for changes in the action
potential during HCM. Specifically, the down regulation of potassium currents was highlighted as
a recurring theme in hypertrophied myocardium and additionally how a fluctuation in L-type
calcium current density typically precedes cardiac hypertrophy.
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Figure 2.9. Transmembrane potential (top) and transient calcium current (bottom) in healthy (left)
and failing (right) cardiomyocytes [20].

From Figure 2.9, there is evidence of a distinction between the repolarization duration of
healthy cardiomyocytes versus diseased cardiomyocytes. The longer the action potential
duration, the more the repolarization process is subject to change. With a change in the shape of
the action potential comes electrical remodeling of the cardiac tissue. The stage of disease is
crucial in determining the degree and character of electrical remodeling and arrhythmic risk [20].
Abnormal automaticity may arise in hypertrophied cardiac tissue in the setting of a reduction in
resting membrane potential. In fact, the most common mechanism of ventricular arrhythmias is
reentry due to abnormal impulse conduction. Such an abnormal conduction rate may contribute to
the production of arrhythmias in hypertrophic and failing hearts [20].
The key components of ventricular myocyte remodeling are the functional expression of a
number of ion channels, transporters and receptors that result in action potential prolongation,
and abnormal 𝐶𝑎2+ handling and aberrant adrenergic signaling. The great challenge that remains
is to use insight provided by in vitro studies to better understand these components of ventricular
myocyte remodeling and how they contribute to arrhythmic mechanisms so that sudden death
may be prevented in patients [20].
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2.6

Ventricular Myocyte Remodeling

Structural remodeling in ventricular myocytes is a major feature of cardiac hypertrophy
and of heart failure. An understanding of the abnormal signaling underlying the associated
cellular changes should have considerable clinical benefits. It is known that myocyte transverse
growth (as opposed to longitudinal growth) is largely responsible for wall thickening during
cardiac hypertrophy [24]. The increase in chamber diameter provides the structural basis for the
elevated wall stress found in heart failure, which can be preceded by hypertrophy. Due to the
spatial arrangement of myocytes within the ventricular wall, cell diameter is primarily responsible
for changes in wall thickness. The myocyte shape alterations during cardiac hypertrophy go
hand-in-hand with changes in ventricular anatomy. Such shape alterations are a result of volume
overloading, leading to proportional growth in the ventricular diameter and is reflected at the
cellular level by the proportional growth of myocyte length and cross-sectional area [24].
There are distinct cellular and molecular events that occur between cardiomyocytes and
non-cardiomyocytes that partially dictate the extent of remodeling in the cardiac tissue from
volume overload. Cardiomyocytes have been proven to show phenotypic modification that results
in cellular hypertrophy accompanied by reexpression of several fetal genes, abnormal 𝐶𝑎2+
handling, oxidative stress, and mitochondrial DNA damage and cardiomyocyte death due to
necrosis or apoptosis. Cardiac fibrosis, or an excessive deposition of the extracellular matrix
proteins, is a hallmark of pathological hypertrophy and heart failure [25]. By forming a barrier
between cardiomyocytes, fibrosis can impair the electrical coupling of cardiomyocytes, leading to
cardiac systolic dysfunction. Resident cardiac fibroblasts, the primary cells that contribute to
fibrosis, are thought to arise from the embryonic proepicardial organ. During fetal development,
their role is to proliferate and grow in size to help the heart to grow. These fetal genes become
less prominent after sufficient fetal development. The cardiomyocyte-specific deletion of genes
has been shown to affect not only cardiomyocyte functionality but also the phenotypes and
functions of fibroblasts [26]. Conversely, recent studies have shown that cardiac fibroblasts
control cardiomyocyte proliferation in the developing ventricles during embryogenesis and that
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fibroblasts promote cardiomyocyte hypertrophy through paracrine factors and ECM. Many growth
factors and cytokines have been shown to act in an autocrine or paracrine fashion to induce
hypertrophic responses in cardiomyocytes and activate fibroblasts. Figure 2.10 shows the
relationship between fibroblasts and myocyte hypertrophy with only some of the contributing
factors identified.

Figure 2.10. Reciprocal interactions between fibroblasts and cardiomyocytes [26].

Insulin-Like Growth Factor-1 (IGF-1) exerts adaptive and cardioprotective effects in
response to stress. In the heart, IGF-1 is mainly expressed in cardiac fibroblasts and activates
downstream signal transducers, such as phosphoinositide 3-kinase (PI3K), leading to
cardiomyocyte hypertrophy. Additionally, cardiac IGF-1 is transactivated by KLF5, which controls
IGF-1 expression in cardiac fibroblasts in response to stress [26]. This induction of IGF-1 is an
essential cardioprotective response. It is theorized that the exacerbation of these factors
contributes to the incitement of pathological hypertrophic cardiomyopathy.
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Figure 2.11. A model for the regulation of fibroblasts by KLF5 during cardiac hypertrophy [26].

2.7

Computationally Modeling Cardiac Tissue

Computational models of ventricular myocyte electrophysiology have evolved over
several decades and have improved the biophysical accuracy and computational efficiency of
modeling electrical dynamics through innovative mathematical approaches. The recent advances
in computational modeling have revolutionized patient diagnostics and treatment by enabling the
construction of three-dimensional models of cardiac tissue that are patient specific. It can be used
to make inferences about biophysical phenomena that are difficult to investigate and cannot be
readily measured. For example, it is challenging to investigate the molecular causes and
structural mechanisms that underlie reentrant arrhythmias, such as tachycardia and fibrillation
[12]. Computational models give researchers the power to manipulate certain biophysical
parameters, providing the advantage of understanding the cellular mechanisms that dictate
electrical and mechanical behaviors.
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Computational models that are patient-specific optimize diagnostic treatment because
they reveal information that would have otherwise been concealed. Using physiology and physics
rather than population statistics to build such models has uncovered more interindividual
variability in pathophysiology, indicating that patient groups are less uniform than previously
thought. The inherent need for individualized treatment for cardiac diseases is rising. With the
increase in computational power and tissue model complexity, simulations are becoming better
able to provide the link between the effects of genetic mutations, physiological regulations or
drugs on protein function and emergent cellular and tissue function or clinical phenotypes.
Three-dimensional (3D) tissue models that incorporate detailed structural information can
provide details about the local electrical behavior that would not be otherwise available. However,
3D models typically assume a continuum and require meshes to be on the order of 100 million
nodes to represent a full human heart. Time steps are required to be on the order of 0.01
seconds to achieve temporal convergence because the upstroke of the cardiac action potential is
very rapid. This makes it challenging to use complex models to study rhythm disturbances where
it is necessary to simulate several cycles of activation [12]. Over recent years, computational
power has increased, allowing for finer meshes and more complex current models to be used in
modeling cardiac tissue. As this power continues to increase in the future, it will become easier to
obtain the most realistic in-silico model of an entire human heart.
To satisfy tissue electrodynamics, cellular-level models can be incorporated into largerscale models as a discrete set of cells or tissues, assuming that at each node point there exists
both intracellular and extracellular space. The fundamental relationships for a three-dimensional
electrical continuum are described below [12].
𝐸 = −∇𝜙

(2.1)

where E is the electric field (with units of Newtons per Coulomb, N/C) and φ is the potential (with
units of Volts, V).
𝐽 = 𝜎𝐸

(2.2)

where J is current density (with units of milliampere per square meter, mA/𝑚 2) and σ is the
conductivity of the medium (with units of Siemens per meter, S/m).
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∇𝐽 = 𝐼𝑣

(2.3)

where 𝐼𝑣 is the source density (with units of ampere per meter A/m).
∇2 𝜙 = −𝐼𝑣 𝜎
otherwise known as Poisson’s equation.
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(2.4)

Chapter 3
METHODS

The Beeler Reuter model was combined with the bidomain model to simulate the
electrical dynamics of a ventricular myocyte for the purpose of investigating the effects of
hypertrophic cardiomyopathy (HCM) on the related action potential dynamics. The bidomain
model was designed to be a three-dimensional cable model, serving as a piece of cardiac tissue,
with the Beeler Reuter model simulating the ionic current fluctuations at each node as an action
potential propagates through the model. The piece of cardiac tissue was designed with a
rectangular shape for simplicity. This simulation is useful for understanding how changes in
ventricular tissue thickness impact electrical impulse propagation and the ventricles’ overall ability
to contract.
While more complex ionic current models have been developed in recent years, the
Beeler Reuter model was selected for its ease of use solving a matrix in MATLAB. The bidomain
model was selected as it is the most mathematically accurate model of electrical behavior within
cardiac tissue and is relatively straightforward to implement. A one-way ANOVA test was run to
examine if there was a significant difference between the action potentials that resulted from
pieces of tissue with different thicknesses

3.1

Beeler Reuter Model

The Beeler-Reuter model was developed in 1977 as an advancement of the HodgkinHuxley model. The formulation of differential equations for the time- and voltage-dependence of
the activation parameters behaves identically to those of the first approach in the Hodgkin-Huxley
model, only here the sodium gates activate and inactive. The Beeler-Reuter model can provide
information on cardiac arrhythmias and ion transport in cardiac cells [9]. This model was selected
for its simplicity and low computational requirements.
The Beeler-Reuter model uses four different ionic currents to simulate the action potential
waveform in mammalian ventricular myocardial cells. The four ionic currents consist of an initial
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fast inward current carried primarily by sodium ions (𝐼𝑁𝑎 ); a secondary or slow inward current
carried mainly by calcium ions (𝐼𝑠 ); a time-activated outward current carried primarily by
potassium ions (𝐼𝑥1); and a time-independent outward current carried mainly by potassium ions
(𝐼𝐾 ). Figure 3.1 shows the four ionic currents and their respective direction in and out of the
ventricular myocyte.

Figure 3.1. A schematic of the four ionic currents used in the Beeler Reuter model.

There are six conduction parameters that describe the degree of activation and
inactivation of the ion-gated channels: d, a calcium activation gate; f, a calcium inactivation gate;
h, a sodium inactivation gate; j, a second sodium inactivation gate; m, a sodium activation gate;
and x1, a potassium activation gate. There are a total of eight parameters that serve as inputs to
the model: the transmembrane potential 𝑉𝑚 , the intracellular calcium concentration Ca, and the
six conduction parameters that describe the degree of activation and inactivation of the ion gated
channels d, f, h, j, m, and x1. The equations for each ionic current and the equation representing
the overall ionic activity in the ventricular myocyte can be found in Figure 3.2. Values of calcium
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dynamics, Nernst potentials, and conductance can be found in Table 3.1. Initial values of the
state variables can be found in Table 3.2.

Figure 3.2. Equations for ionic current activity in the Beeler-Reuter model [22].

Table 3.1. Values of Calcium Dynamics, Nernst Potentials, and Conductance
𝒅[𝑪𝒂]𝒊
𝒅𝒕

−10−7 𝐽𝐶𝑎 + 0.07(−10−7 − [𝐶𝑎]𝑖 )

𝑬𝑵𝒂

50

𝑬𝑪𝒂

−82.3 − 13.0287 ∗ 𝑙𝑛[𝐶𝑎]𝑖

𝑮𝑵𝒂

4

𝑮𝑵𝒂𝑪

0.003

𝑮𝑪𝒂

0.09
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Table 3.2. Initial Values of State Variables
State Variable

Value

Dimensions

𝑉𝑚

-84.62

mV

[𝐶𝑎]𝑖

10−7

mol/L

d

0.003

N/A

f

1

N/A

h

0.99

N/A

j

0.97

N/A

m

0.011

N/A

x1

0.0074

N/A

The action potential of a single ventricular myocyte, as described by the Beeler Reuter
model, is represented in Figure 3.3. The code used to create the action potential can be found in
Appendix A.

Figure 3.3. The action potential of the Beeler-Reuter model within a ventricular myocyte.
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3.2

Bidomain Model

The bidomain model serves as the most complete representation of cardiac tissue. It is
based on the assumption that, at the cell scale, the cardiac tissue can be partitioned into two
ohmic conducting media, separated by the cell membrane: intracellular and extracellular domains
[23]. It recognizes that cardiac tissue is electrically anisotropic and that, during electrical
activation, current flows in both the extracellular and intracellular domains. Two of the most
commonly measured cardiac electrical signals, extracellular potential and transmembrane
potential, are direct model outputs [24].
The bidomain model was developed to be the first mathematical model that could
describe the electrical properties of cardiac tissue which initially helped to unravel the
mechanisms of how a pacemaker excites the heart. It represents cardiac tissue as a
multidimensional cable that can be represented by a network of resistors and capacitors. For
example, a two-dimensional bidomain model consists of one upper grid of resistors and one lower
grid of resistors (i.e., the extracellular space and intracellular space, respectively) coupled by
resistors and capacitors (i.e., the membrane) [24].
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Figure 3.4. Two-dimensional bidomain network [29].
While Figure 3.4 represents a two-dimensional representation of myocardial tissue, a true
working myocardium is regarded as a three-dimensional network of coupled excitable elements
[27]. The resistor and capacitor in parallel are analogous to the gap junction between
cardiomyocytes. Thus, the z-direction can be thought of as units of cardiomyocytes along with the
intercalated discs that separate them. To perform appropriate simulations of cardiac
electrophysiology, the bidomain model must be coupled with an ionic model to capture the full
range of cell membrane kinetics [25]. An ionic model describes the chemical and electrical
gradients across the cell membrane of a single cardiac cell by simulating the subcellular
processes that take place within a selectively permeable membrane, which is permeable to
different ions under different conditions [7].
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Figure 3.5. Ionic model represented by an equivalent circuit model.

The current flowing into the top center node from the capacitor and resistor in parallel in
Figure 3.5 can be represented by the following equation:
𝐶𝑚 𝑑𝑉𝑚 𝑑𝑡 + 𝐼𝑁𝑎 + 𝐼𝐾 + 𝐼𝑥1 + 𝐼𝑠 − 𝐼𝑠𝑡𝑖𝑚 = 0
(3.1)
This equates to the right-hand side of the second bidomain equation (Eq. 3.8) described on page
34. The ionic currents used in Equation (3.1) represent the Beeler Reuter model. The onedimensional equivalent circuit model in Figure 3.5 is the unit that is repeated in the multidimensional cable model shown in Figure 3.4.
Several ionic models are available with varying differential equations. The more complex
models have been developed in recent years and are advancements on ionic models developed
previously. Within cardiac tissue, changes occur rapidly over a small spatial domain, so
discretized versions of these models must be solved on a fine computational grid and small-time
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steps must be used. For very simple ionic models, the bidomain model can be discretized and
numerical solutions can be computed for all variables simultaneously [25].

Figure 3.6. Flowchart of the steps taken to implement the bidomain model into MATLAB.
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Table 3.3. Parameters Used in the Implementation of the Bidomain Model
Parameter

Description

Value

Δt

Size of time step

0.02 𝑚𝑠

h

Distance between node points

0.2E-3 𝑚

𝜎𝑖 , 𝑥

Intracellular conductivity in the x-direction

0.2 𝑚

𝜎𝑖 , 𝑦

Intracellular conductivity in the y-direction

0.02 𝑚

𝜎𝑖 , 𝑧

Intracellular conductivity in the z-direction

0.02 𝑚

𝜎𝑒 , 𝑥

Extracellular conductivity in the x-direction

0.2 𝑚

𝜎𝑒 , 𝑦

Extracellular conductivity in the y-direction

0.08 𝑚

𝜎𝑒 , 𝑧

Extracellular conductivity in the z-direction

0.08 𝑚

𝜎𝑏

Conductivity of the surrounding bath

0.2 𝑚

β

Surface area to volume ratio

3E5 𝑚

𝐶𝑚

Membrane capacitance per unit surface area

1 𝑚2

𝑉𝑚 , 𝑡 = 0

Initial membrane potential

-83.3 𝑚𝑉

𝐼𝑆𝑡𝑖𝑚

Stimulus current

𝑆

𝑆

𝑆

𝑆

𝑆

𝑆

𝑆

1

𝐹

3E5

𝑚𝐴
𝑚2

These values do not change within MATLAB model constructed in this thesis. The model
was designed to be a continuum, wherein the electrical properties remain constant throughout the
simulations. However, it is logical to assume that some of these values would change in a true
case of hypertrophic cardiomyopathy. Given that cardiac disease does not progress uniformly,
tissue conductivity may not be uniform throughout the tissue as it thickens. Additionally, the
distance between node point (or reference points) will vary and be inconsistent by nature.
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3.2.1

Mathematical Formulation of the Bidomain Equations

To define the mathematical formulation of the bidomain model, it is helpful to first start
with the definition of transmembrane potential:
𝑉𝑚 = 𝜙𝑖 − 𝜙𝑒

(3.2)

Here, 𝜙𝑖 represents intracellular potential and 𝜙𝑒 represents extracellular potential.
The basis of the bidomain model is that the net current flux between the intracellular and
extracellular domains is zero everywhere and takes on the following form:
−𝛻 ∙ 𝐽𝑖 = 𝛻 ∙ 𝐽𝑒

(3.3)

By taking equations (2.1) and (2.2) and substituting them in for 𝐽𝑖 and 𝐽𝑒 , respectively, in
equation (3.3), and by substituting in equation (3.2) for 𝜙𝑖 , the first bidomain equation is is written
as:
∇ ∙ (𝜎𝑖 ∇𝑉𝑚 ) = −𝛻 ∙ ((𝜙𝑖 + 𝜙𝑒 )𝛻𝜙𝑒 )

(3.4)

Additionally,
−𝛻 ∙ 𝐽𝑖 = 𝛽𝐼𝑚 − 𝐼𝑠

(3.5)

where β is the surface-to-volume ratio, 𝐼𝑚 is the transmembrane current density and 𝐼𝑠 is
an externally imposed current source density. From this expression, it can be shown that
∇ ∙ (𝜎𝑖 ∇𝑉𝑚 ) + ∇ ∙ (𝜎𝑖 ∇𝜙𝑒 ) = 𝛽𝐼𝑚 − 𝐼𝑠

(3.6)

It’s important to note that we define 𝐼𝑚 as
𝐼𝑚 = 𝐶𝑚

𝛿𝑉𝑚
𝛿𝑡

+ 𝐼𝑖𝑜𝑛

(3.7)

where 𝐼𝑖𝑜𝑛 is the net current carried by the transmembrane ion channels. We combine
equations (3.6) and (3.7) to get the second bidomain equation:
∇ ∙ (𝜎𝑖 ∇𝑉𝑚 ) + ∇ ∙ (𝜎𝑖 ∇𝜙𝑒 ) = 𝛽 (𝐶𝑚
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𝛿𝑉𝑚
𝛿𝑡

+ 𝐼𝑖𝑜𝑛 ) − 𝐼𝑠

(3.8)

3.2.2

Boundary Conditions of the Bidomain Equations

The boundary condition used for solving the bidomain equations is that there is no
current flow out of the intracellular domain at the surface of the heart. This can be written as
(𝜎𝑖 ∇𝜙𝑖 ) ∙ 𝑛 = 0

(3.9)

Where n is a unit vector outwardly normal to the myocardial surface. To match the
formulation of the bidomain equations, this boundary condition can be further rewritten as
(𝜎𝑖 ∇𝑉𝑚 ) ∙ 𝑛 = −(𝜎𝑖 ∇𝜙𝑒 ) ∙ 𝑛
3.2.3

(3.10)

Solving the Bidomain Equations

The bidomain equations must be both time discretized and spatially discretized. The time
discretization will be solved using a forward Euler method and the spatial discretization will be
solved using the finite difference method. The potential at each point in the tissue is a function of
its neighboring points and can be represented through the following equation:
∇ ∙ (𝜎∇𝜙) = 𝜎∇2 𝜙 = 𝜎𝑥

∂2𝜙
∂𝑥 2

∂2 𝜙

+ 𝜎𝑦 ∂𝑦 2 + 𝜎𝑧

∂2𝜙
∂𝑧 2

(3.11)

3.2.3.1 Time Discretization

The time discretization of the bidomain model will be solved using the forward Euler
method. This method is a first-order numerical procedure for solving ordinary differential
equations with a given initial value. It is the most basic explicit method for numerical integration of
ordinary differential equations and was thus selected for its simplicity.

3.2.3.2 Spatial Discretization

The spatial discretization of the bidomain model will be solved using the finite-difference
method in this paper. The finite-difference method, while not often used for irregular shaped
geometries such as cardiac tissue, has a simple formulation, low computational requirements,
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and is fast to solve [26]. The finite difference technique is well-suited for a discontinuous
myocardial structure with no-flux boundaries. It approximates the solution of differential equations
by using the finite differences of the neighboring node points [7]. This is implemented by a
Laplacian matrix, described by the operator ∇2 𝜎. Numerically, this technique is straightforward,
but it requires a uniformly spaced solution grid. For a three-dimensional model, sufficient
discretization requires a large quantity of node points, thereby increasing the computational
requirements. To decrease computational time, the quantity of node points in each direction was
restricted to ten nodes. A linear system of algebraic equations arises from the spatial
discretization which will be solved with an iterative solver. An iterative solver was selected over a
direct solver due to its efficiency in solving large matrices [7].

3.3

Simulating Electrical Activity in a 3D Model of Cardiac Tissue

The geometry of the three-dimensional piece of cardiac tissue is constructed
mathematically in MATLAB. The piece of heart tissue is surrounded by a conductive bath. A
stimulus current is applied at one node within the tissue, the location of which does not change
throughout the simulations. The development and progression of the electrical activity, initiated by
the stimulus, is simulated with the bidomain model. To alternate the thickness of the tissue, the
dimension in the z-direction was manually altered and the script was re-run to produce an action
potential that corresponded to that exact thickness. The dimensions in the x-direction and ydirection were kept equal and remained the same throughout the simulations for simplicity.

3.4

Statistical Analysis

A one-way ANOVA test was run to examine if there was a significant difference between
the action potentials that resulted from pieces of tissue with different thicknesses. The array of the
membrane potential values at each time point was saved from each time the script was run with a
different thickness. Each set of membrane potential values was inserted into a single column in
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JMP, and the one-way ANOVA test measured the differences between each set. The resulting pvalue was used as the determining factor as to whether the membrane potential values at each
time were significantly different between each run with a different tissue thickness.
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Chapter 4
RESULTS

The use of the bidomain model in combination with the Beeler Reuter model for
replicating the effects of hypertrophic cardiomyopathy on the action potential of a ventricular
myocyte was investigated. The bidomain model was incorporated to construct the geometry of
and describe the electrical conductivity of the tissue. The Beeler Reuter model was incorporated
to describe the ionic current activity at each node. The two models were combined in MATLAB.
The output of the model was the action potential, represented as membrane potential over time,
as it propagated through the tissue model. The thickness of the tissue model was manually
altered, and the membrane potential output and values were collected after each run. Phases two
and three of the action potential were specifically investigated to observe whether they prolonged
(evidence of hypertrophic cardiomyopathy). This active model was compared to a passive model,
as well as to a Beeler Reuter model found in the literature [9], for validation.

4.1

Simulating Electrical Activity of a 3D Model of Ventricular Tissue

An action potential was created at tissue thicknesses of 5, 6, 7, 8, 9, and 10 nodes. The
elapsed time was kept at 500 milliseconds for each run to simplify the visual comparison between
the action potentials for each thickness. An overlay of all action potential runs can be seen in
Figure 4.7.
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Figure 4.1. The action potential of the tissue with a thickness of 5 nodes.
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Figure 4.2. The action potential of the tissue with a thickness of 6 nodes.
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Figure 4.3. The action potential of the tissue with a thickness of 7 nodes.
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Figure 4.4. The action potential of the tissue with a thickness of 8 nodes.
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Figure 4.5. The action potential of the tissue with a thickness of 9 nodes.
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Figure 4.6. The action potential of the tissue with a thickness of 10 nodes.
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Figure 4.7. The overlaid action potentials of all tissue thicknesses.

4.2

Model Validation

For this simulation, three forms of validation were utilized in order to first validate the
effect of the stimulation current within the model; then to validate the shape of the action
potential; and finally, to validate the electrical components (of the bidomain model) representation
of the physiological components. For validating the effectiveness of the stimulation current
present within the model, it was sufficient to compare the model output, which is considered to be
an “active” model due to the presence of a stimulation current, with the output of a “passive”
model, wherein there is no stimulation current present. This validation technique verified the
effect of the stimulus current on the action potential. In Figure 4.8, the passive model was
simulated by omitting the stimulation current from the ionic current script in MATLAB. While there
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is no stimulation current present, the membrane potential is still changing over time. The reason
for this continual change in membrane potential over time is theorized to be a result of the
continuation of the four ionic currents present within the Beeler Reuter model being held at steady
state where no external stimulus is applied.

Figure 4.8. Membrane potential over time described by a passive model where the stimulation
current was omitted.

The shape of the model was validated by visually comparing it to a plot of membrane
potential over time produced by the Beeler Reuter model found in the literature. Figure 4.9 shows
the membrane potential over time as it is produced by the Beeler Reuter model from Beeler et. al
[9].
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Figure 4.9. A standard action potential described by the Beeler Reuter model found in the
literature [9].

Public access to clinical data such as human action potential dynamics, including those
taken from cardiac tissue cells, is scarce or limited by practical or ethical concerns [10]. For this
reason, the simulation described in this paper was not validated through experimental data.
However, computational modeling based on experimental data is an important component in
cardiac electrophysiological research and has been used to test a variety of mechanistic
hypotheses [10].
The accuracy of the electrical representation of the physiological components is validated
by describing the role of gap junctions, how they are affected during hypertrophic
cardiomyopathy, and how their electrical equivalents predispose a prolonged action potential
during cases of hypertrophy. The lengthening of the ventricular action potential is commonly
observed in both cardiac hypertrophy and failure. Hypertrophic cardiomyopathy in the ventricles is
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known to delay the recovery of excitability and is also associated with altered electronic coupling
between cells, slowed conduction, and a dispersion of refractoriness. There is evidence of
diminished outward current during hypertrophy which leads to action potential prolongation.
Currently, an understanding of mechanisms underlying hypertrophic action potential prolongation
is limited and, as a result, the means of treating hypertrophy-associated action potential
prolongation is also limited.
Gap junctions provide a chemical and electrical connection between cardiac cells,
allowing a coordinated action potential propagation. They determine how much depolarizing
current passes from excited to non-excited regions of the network. In an adult myocardium, a
given cardiomyocyte is typically electrically coupled to about 10-11 adjacent cells with gap
junctions being predominantly localized at the intercalated discs at the ends of the rod-shaped
cells [27]. The geometry of the interconnected cells and the number, size, and location of gap
junction plaques between them all dictate the conductive properties of those cells. The area of the
plaque within the gap junction directly impacts the conduction velocity of an action potential
propagating from one cell to the next [28]
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Figure 4.10. (a) Coupled cardiomyocytes. (b) Intercalated discs from a section of stained cardiac
tissue. (c) Gap junctions between cardiomyocytes [11]

Gap junction remodeling has been found to precede virtually all cardiac diseases
predisposing to arrhythmias. In hypertrophic ventricles in particular, the reduction of gap junction
plaque area per intercalated disc is more widespread than in other types of cardiac disease [28].
A decrease in gap junction plaque area correlates with a decrease in conduction velocity, leading
to a prolonged action potential.
As previously stated in section 3.2, the bidomain model is composed of a network of
resistors representing the extracellular membrane and another network of resistors representing
the intracellular membrane coupled by a series of a resistor and a capacitor in parallel. A diagram
of a two-dimensional bidomain model can be seen in Figure 4.11.
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Figure 4.11. Two-dimensional bidomain network [29].

A true working myocardium is regarded as a three-dimensional network of coupled
excitable elements [27]. The resistor and capacitor in parallel are analogous to the gap junction
between cardiomyocytes. Altering the resistance in this parallel combination can impede the
conduction of electrical signals, which equates to altering the flow of current through gap
junctions [30].
Increasing the resistance in parallel with the conductance will slow the conduction
velocity of the action potential. This correlates with why the latter half of the action potential
becomes more and more prolonged as the tissue thickens. Additionally, as the tissue thickens,
the resistance will increase in the z-direction of the tissue, making it progressively more difficult
for an action potential to propagate laterally.
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4.3

Statistical Analysis

A one-way ANOVA test was run in JMP to determine if any of the data sets were
significantly different from one another. The test results yielded a p-value of <0.0001 and an F
ratio of 23.6962. Therefore, the null hypothesis can be rejected, and it can be confidently stated
that at least one of the groups means differs from the rest. In other words, the tissue size
statistically affects the shape of the action potential as it propagates through the tissue
membrane. In Figure 4.12, the mean membrane potential and first standard deviation for each
group is designated by a green rhombus.

Figure 4.12. The average membrane potential values for tissue sizes of 5 nodes, 6 nodes, 7
nodes, 8 nodes, 9 nodes, and 10 nodes thickness.
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Figure 4.13. Results from the one-way ANOVA test between each set of membrane potential
values from each tissue thickness. The p-value is <0.0001 and the F Ratio value is 23.6962.
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Chapter 5
DISCUSSION

This work explored the use of a computational model for investigating changes in the
shape of a cardiac action potential brought on by ventricular tissue thickness changes from
hypertrophic cardiomyopathy. It was originally hypothesized that the computational model would
be able to successfully correlate an increase in ventricular tissue thickness with a prolonged
cardiac action potential. It is known that specifically phases two and three of the cardiac action
potentials elongate in cases of hypertrophic cardiomyopathy (Figure 2.5 indicates each phase of
the cardiac action potential). These phases were visually investigated as a part of confirming the
correlation. The model successfully predicted that an increase in ventricular wall thickness
correlates with a prolonged action potential duration. A one-way ANOVA analysis revealed that at
least one of the action potentials propagating through a piece of ventricular wall tissue was
significantly different from the action potentials propagating through ventricular walls with different
thicknesses. The identification of a relationship between cardiac tissue thickness and action
potential shape lends insight into how electrical signal transmission can change during the
progression of cardiac disease.

5.1

Implications

This model is useful because it analyzes the mechanisms by which an electric field
interacts with cardiac tissue as the tissue increases in size, such as in the case of hypertrophic
cardiomyopathy. This analysis shows how an action potential will propagate in the case of HCM,
lending insight into how long it will take for the heart to fully contract as its ventricular tissue
thickness increases.
The validation demonstrated that there is a difference between the active and passive
ionic models implemented with the bidomain model, meaning that the stimulus current was
appropriate and has an impact on the resulting action potential. The validation further showed
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that there is a significant difference between the action potential measurement stemming from
pieces of ventricular tissue with differing thicknesses.
In the medical field, there is a need for improving the specialized treatment of cardiac
diseases and arrhythmias by tailoring therapy so that it is unique to each patient. This model can
serve as a steppingstone for creating more in-depth models that will be able to predict the specific
electrical behavior of each patient’s heart by incorporating their individual cardiac geometry or
ionic current fluctuations into the model. Such a model could reveal how patients may respond to
treatment as no two hearts are the same. It is a non-invasive, efficient preliminary model to
examine how patients may respond to treatment based on their unique cardiac geometry or ionic
current dynamics.

5.2

Limitations

The major limitations of this model can be summarized by three main points: a lack of
computational power to implement more complex ionic models; restricted access to experimental
data on cardiac action potential dynamics to further validate the model; and assuming continuum
behavior throughout the hypertrophied cardiac tissue.
As the complexity of ionic models increases, the accuracy of such ionic models also
increases. The Beeler Reuter model, while useful, was created in 1977 and currently stands as
one of the simpler ionic models with only 8 state variables. In recent years, ionic models have
been developed that incorporate more ionic currents with some models having up to 67 state
variables [31]. These complex models are more able to provide an accurate representation of the
true ionic conductance inside of a cardiomyocyte. However, with more state variables in these
complex models comes a demand for greater computational power. For this study, a simple ionic
model was selected to reduce computational demand, even though this limited the accuracy of
the ionic behavior within a cardiomyocyte.
After conducting a thorough literature review, it was discovered that there is very limited
access to any experimental data describing the dynamic behavior of cardiac tissue at the cellular
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level. This kind of information is challenging to collect and is not readily available to the public by
practical or ethical concerns [10].
Continuum behavior was assumed for simplicity, but continuum behavior is not entirely
depictive of diseased tissue. Since the progression of a disease is not regulated, the electrical
behavior is not uniform throughout the entire tissue and tends to short in diseased areas.

5.3

Future Work

The work done to evaluate influential parameters within this model could be expanded
upon in the future. It may be useful to investigate the quantitative relationships between tissue
thickness and the length of the plateau phase of the cardiac action potential to further validate the
effect of the tissue thickness on the length of the plateau phase. One could find the area under
the curve of each individual output in Figure 4.7 and compare those values in a statistical
analysis. A suggested statistical analysis to use in the future would be a conjoint analysis, which
provides more information than a one-way ANOVA test. A conjoint analysis is traditionally used in
marketing research, but it would be beneficial to consider using in order to determine how
different parameters influence membrane potential.
Another example of future work in this area would be to incorporate different ionic models
other than the Beeler Reuter model to investigate if and how that would change the shape of the
action potential during hypertrophic cardiomyopathy. Given that their computer has enough
processing power, future researchers could combine human models, such as the Ten Tusscher
[36] or Iyer Mazhari Winslow [37] models, with the three-dimensional bidomain model to study the
human heart’s electrical behavior during hypertrophic cardiomyopathy. Human models, as
opposed to generic models, are inherently more accurate in predicting the electrical behavior of
human cardiac tissue and would thus be a closer representation of the true electrical behavior in
diseased or non-diseased tissue.
The study performed in this thesis can be further validated by conducting an in vitro study
to confirm the electrical behavior of hypertrophied cardiac tissue. Artificial hypertrophy (through
mechanical stretch) could be performed on bovine cardiac tissue using a technique similar to that
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described in the paper by Ovchinnikova et al [2]. It would be challenging to obtain human cardiac
tissue, so bovine cardiac tissue would be recommended as it would be more readily available and
perform similarly to that of human cardiac tissue.
A common technique that was found in the previous literature that was not utilized in this
paper was the fluctuation of ionic current concentrations to examine how the electrical behavior of
the heart changed. The concentration of each ionic current has been previously found to impact
the electrical activity, but it hasn’t yet been investigated for the case of hypertrophic
cardiomyopathy. Altering the ionic current concentrations in the computational model for HCM or
another cardiac disease would be beneficial as it is another avenue towards gaining insight on
how the ionic concentrations affect the dynamics of the electrical behavior in the heart. A future
investigation of potential interest could lie in creating a computational model of myocyte
electrophysiology with an integration of and emphasis on 𝐶𝑎2+ transient dynamics. An integrative
model of myocyte electromechanics has potential in the realm of FHC research for several
reasons, the most prominent of which being that many FHC mutations are associated with high
risk for lethal arrhythmias and the myocyte is the simplest system to observe in which sarcomeric
mutations could exert an effect on electrical activity in the heart. Myocytes are the simplest cells
to experimentally prepare and observe the effects of FHC mutations on twitch characteristics. A
computational biophysically detailed electrical myocyte model could be created to validate the
effects of 𝐶𝑎2+ transient current on cardiac muscle twitch in vitro.
For an in vitro study, a new approach being explored at present is to create induced
pluripotent stem cells from human somatic tissues that can be differentiated into heart cells.
Myocytes derived from patients harboring FHC mutations could then be used for functional cellscale assays or as a means of obtaining mutant proteins for molecular studies. An emerging
trend from similar studies has revealed that mutations linked to HCM tend to increase 𝐶𝑎2+
sensitivity of the myofilaments, while the small number of mutations linked to dilated
cardiomyopathy (DCM) tend to decrease it. It seems unlikely that a single parameter would be
able to describe a multi-dimensional phenotypic space of FHC, but the sensitivity of 𝐶𝑎2+ would
still be useful to look into with regards to its impact on electrical dynamics related to HCM.
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5.4

Conclusions

The use of this computational model could improve clinical research efforts by serving as
a form of validation for conducting in vitro experiments on hypertrophied cardiac tissue to gain a
better understanding of the root mechanisms of hypertrophic cardiomyopathy or related cardiac
diseases. By being able to input model parameters that are specific to patients’ cardiac geometry,
personalized treatment can be delivered to better target and advance the recovery of cardiac
diseases such as hypertrophic cardiomyopathy.

58

BIBLIOGRAPHY

[1]

Passini, Elisa, et al. “Mechanisms of pro-Arrhythmic Abnormalities in Ventricular

Repolarization and Anti-Arrhythmic Therapies in Human Hypertrophic Cardiomyopathy.” Journal
of Molecular and Cellular Cardiology, Academic Press, July 2016,
www.ncbi.nlm.nih.gov/pmc/articles/PMC4915817/.

[2]

Ovchinnikova, Ekaterina, et al. “Modeling Human Cardiac Hypertrophy in Stem Cell-

Derived Cardiomyocytes.” Stem Cell Reports, vol. 10, no. 3, 2018, pp. 794–807.,
doi:10.1016/j.stemcr.2018.01.016.

[3]

Frey, Norbert, et al. “Hypertrophy of the Heart.” Circulation, vol. 109, no. 13, 2004, pp.

1580–1589., doi:10.1161/01.cir.0000120390.68287.bb.

[4]

Ibrahim, Adebisi O., et al. “Dynamical Modelling of Cardiac Electrical Activity Using

Bidomain Approach: The Effects of Variation of Ionic Model Parameters.” Journal of Biomedical
Science and Engineering, vol. 06, no. 06, 2013, pp. 598–608., doi:10.4236/jbise.2013.66076.

[5]

Chang, Eugene Tze-Yeng. “Towards Understanding the Electrogram: Theoretical &

Experimental Multiscale Modelling of Factors Affecting Action Potential Propagation in Cardiac
Tissue.” Imperial College London, 2013.

[6]

Tanyous, Fred (Farid). “Mapping Electrical Propagation in the Cardiac Sinoatrial Node:

An Experimental and Computational Modelling Approach.” The University of New South Wales,
2019.

[7]

Bantle, Annabel Christin. “Mathematically Modeling the Electrical Activity of a Wedge of

Left Ventricular Heart Tissue.” Aalborg University, 2019.

59

[8]

Marian, Ali J, and Eugene Braunwald. “Hypertrophic Cardiomyopathy: Genetics,

Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.” Circulation research vol. 121,7
(2017): 749-770. doi:10.1161/CIRCRESAHA.117.311059

[9]

Beeler, G W, and H Reuter. “Reconstruction of the action potential of ventricular

myocardial fibres.” The Journal of physiology vol. 268,1 (1977): 177-210.
doi:10.1113/jphysiol.1977.sp011853

[10]

Gray, Richard A., and Michael R. Franz. “A Model for Human Action Potential Dynamics

in Vivo.” American Journal of Physiology-Heart and Circulatory Physiology, vol. 318, no. 3, 2020,
doi:10.1152/ajpheart.00557.2019.

[11]

L. Biga, S. Dawson, A. Harwell, R. Hopkins, J. Kaufmann, M. LeMaster,

P. Matern, K. Morrison-Graham, D. Quick, J. Runyeon, and L. Whittier, Anatomy Physiology.
Open Oregon State, Oregon State University, 2018.

[12]

Sigg, Daniel C. Cardiac Electrophysiology Methods and Models. Springer, 2010.

[13]

Wei, Xingyu. “Physiology, Cardiac Repolarization Dispersion and Reserve.” StatPearls

[Internet]., U.S. National Library of Medicine, 30 Apr. 2020,
www.ncbi.nlm.nih.gov/books/NBK537194/.

[14]

“Anatomy and Function of the Heart's Electrical System.” Johns Hopkins Medicine,

www.hopkinsmedicine.org/health/conditions-and-diseases/anatomy-and-function-of-the-heartselectrical-system.

[15]

Campbell, Stuart G., and Andrew D. McCulloch. “Multi-Scale Computational Models of

Familial Hypertrophic Cardiomyopathy: Genotype to Phenotype.” Journal of The Royal Society
Interface, vol. 8, no. 64, 2011, pp. 1550–1561., doi:10.1098/rsif.2011.0184.

[16]

Bers, D. Cardiac excitation–contraction coupling. Nature 415, 198–205 (2002).

https://doi.org/10.1038/415198a

60

[17]

Nerbonne JM, Kass RS. Molecular physiology of cardiac repolarization. Physiol Rev.

2005 Oct;85(4):1205-53. doi: 10.1152/physrev.00002.2005. PMID: 16183911.

[18]

Abdul Kadir, Lina, et al. “Emerging Roles of the Membrane Potential: Action Beyond the

Action Potential.” Frontiers, Frontiers, 2 Nov. 2018,
www.frontiersin.org/articles/10.3389/fphys.2018.01661/full.

[19]

Webster, John G. Medical Instrumentation: Application and Design. J. Wiley & Sons,

1998.

[20]

Cha, Chae Young, and Akinori Noma. “Steady-State Solutions of Cell Volume in a

Cardiac Myocyte Model Elaborated for Membrane Excitation, Ion Homeostasis and 𝐶𝑎2+
Dynamics.” Journal of Theoretical Biology, vol. 307, 11 May 2012, pp. 70–81., doi:https://doiorg.ezproxy.lib.calpoly.edu/10.1016/j.jtbi.2012.04.025.

[21]

Aulakh, M. Why old heart cells don't multiply. Nat Rep Stem Cells (2009).

https://doi.org/10.1038/stemcells.2009.31

[22]

Gordon F. Tomaselli, Eduardo Marbán, Electrophysiological remodeling in hypertrophy

and heart failure, Cardiovascular Research, Volume 42, Issue 2, May 1999, Pages 270–283,
https://doi.org/10.1016/S0008-6363(99)00017-6

[23]

Coltart DJ, Meldrum SJ. Hypertrophic cardiomyopathy. An electrophysiological study. Br

Med J. 1970 Oct 24;4(5729):217-8. doi: 10.1136/bmj.4.5729.217. PMID: 5528752; PMCID:
PMC1819778.

[24]

Gerdes, A.Martin. “Cardiac Myocyte Remodeling in Hypertrophy and Progression to

Failure.” Journal of Cardiac Failure, vol. 8, no. 6, 2002, doi:10.1054/jcaf.2002.129280.

61

[25]

Tirziu, D. “Cardiac Hypertrophy: Signaling and Cellular Crosstalk.” Encyclopedia of

Cardiovascular Research and Medicine, 2018, pp. 434–450., doi:10.1016/b978-0-12-8096574.99834-x.

[26]

Takeda, Norifumi, and Ichiro Manabe. “Cellular Interplay between Cardiomyocytes and

Nonmyocytes in Cardiac Remodeling.” International Journal of Inflammation, vol. 2011, 2011, pp.
1–13., doi:10.4061/2011/535241.

[27]

“Beeler-Reuter Model of Ventricular Myocardial Action Potential.” University of Rhode

Island, 2006.

[28]

Boulakia, Muriel, et al. “Mathematical Modeling of Electrocardiograms: A Numerical

Study.” Annals of Biomedical Engineering, vol. 38, no. 3, 2009, pp. 1071–1097.,
doi:10.1007/s10439-009-9873-0.

[29]

Efimov, Igor R, et al., editors. Cardiac Bioelectric Therapy: Mechanisms and Practical

Implications. SPRINGER, 2009.

[30]

Sundnes J, Nielsen BF, Mardal KA, Cai X, Lines GT, Tveito A. On the computational

complexity of the bidomain and the monodomain models of electrophysiology. Ann Biomed Eng.
2006 Jul;34(7):1088-97. doi: 10.1007/s10439-006-9082-z. Epub 2006 May 16. PMID: 16773461.

[31]

H. I. Saleheen and K. T. Ng, "A new three-dimensional finite-difference bidomain

formulation for inhomogeneous anisotropic cardiac tissues," in IEEE Transactions on Biomedical
Engineering, vol. 45, no. 1, pp. 15-25, Jan. 1998, doi: 10.1109/10.650347.

[32]

Rohr, S. “Role of Gap Junctions in the Propagation of the Cardiac Action Potential.”

Cardiovascular Research, vol. 62, no. 2, 2004, pp. 309–322.,
doi:10.1016/j.cardiores.2003.11.035.

[33]

Jongsma, Habo J., and Ronald Wilders. “Gap Junctions in Cardiovascular Disease.”

Circulation Research, vol. 86, no. 12, 2000, pp. 1193–1197., doi:10.1161/01.res.86.12.1193.

62

[34]

J. Roth, Bradley. “Numerical Simulations of Cardiac Tissue Excitation and Pacing Using

the Bidomain Model.” The Open Pacing, Electrophysiology & Therapy Journal, vol. 4, no. 1, 2011,
pp. 1–9., doi:10.2174/1876536x01104010001.

[35]

Robinson, Martha M et al. “Modeling biological membranes with circuit boards and

measuring electrical signals in axons: student laboratory exercises.” Journal of visualized
experiments : JoVE ,47 2325. 18 Jan. 2011, doi:10.3791/2325

[36]

Ten Tusscher, K. H., et al. “A Model for Human Ventricular Tissue.” American Journal of

Physiology-Heart and Circulatory Physiology, vol. 286, no. 4, 2004,
doi:10.1152/ajpheart.00794.2003.

[37]

Iyer V, Mazhari R, Winslow RL. A computational model of the human left-ventricular

epicardial myocyte. Biophys J. 2004 Sep;87(3):1507-25. doi: 10.1529/biophysj.104.043299.
PMID: 15345532; PMCID: PMC1304558.

63

APPENDIX A

Beeler-Reuter Model for Membrane Potential Through a Single Cell

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%
%
%
Function:
BR_Prime
%
Revision Date: 11/16/2020
%
Author:
Socrates Dokos
%
Co-Author:
Julia Kelley
%
%
Function for solving the Beeler-Reuter (1977) model. For use with
%
ode15s.
%
%
Arguments:
t
= time (ms)
%
%
y
= vector of initial values for membrane
potential (V),
%
calcium concentration (Ca), and governing
parameters
%
(x1, m, h, j, d, and f)
%
%
Returns:
y_prime
= vector of approximated values for
membrane
%
potential (V), calcium concentration
(Ca),
%
and governing parameters(x1, m, h, j, d,
and f)
%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%
function y_prime = BR_Prime(t,y)
global Cm r_Ca Ca_SR k_up A_K1 A_x1 g_Na g_NaC V_Na g_s A_s t_on t_dur;
y_prime = zeros(8,1);
V = y(1);
Ca = y(2);
x1 = y(3);
m = y(4);
h = y(5);
j = y(6);
d = y(7);
f = y(8);
alpha_x1 = 0.0005*exp(0.083*(V+50))/(exp(0.057*(V+50))+1);
beta_x1 = 0.0013*exp(-0.06*(V+20))/(exp(-0.04*(V+20))+1);
alpha_m = -(V+47)/(exp(-0.1*(V+47))-1);
beta_m = 40*exp(-0.056*(V+72));
alpha_h = 0.126*exp(-0.25*(V+77));
beta_h = 1.7/(exp(-0.082*(V+22.5))+1);
alpha_j = 0.055*exp(-0.25*(V+78))/(exp(-0.2*(V+78))+1);
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beta_j = 0.3/(exp(-0.1*(V+32))+1);
alpha_d = 0.095*exp(-0.01*(V-5))/(exp(-0.072*(V-5))+1);
beta_d = 0.07*exp(-0.017*(V+44))/(exp(0.05*(V+44))+1);
alpha_f = 0.012*exp(-0.008*(V+28))/(exp(0.15*(V+28))+1);
beta_f = 0.0065*exp(-0.02*(V+30))/(exp(-0.2*(V+30))+1);
V_Ca = -82.3 - 13.0287*log(Ca);
i_K1 = A_K1*(4*(exp(0.04*(V+85))1)/(exp(0.08*(V+53))+exp(0.04*(V+53)))+
0.2*(V+23)/(1-exp(-0.04*(V+23))));
i_x1 = A_x1*x1*(exp(0.04*(V+77))-1)/exp(0.04*(V+35));
i_Na = (g_Na*m^3*h*j+g_NaC)*(V-V_Na);
i_s = g_s*d*f*(V-V_Ca);

if((t>= t_on)&&(t<t_on+t_dur))
i_stim = A_s;
else
i_stim = 0;
end
% active model:
% y_prime(1) = -(1/Cm)*(i_K1 + i_x1 + i_Na + i_s - i_stim);
% passive model:
y_prime(1) = -(1/Cm)*(i_K1 + i_x1 + i_Na + i_s);
y_prime(2)
y_prime(3)
y_prime(4)
y_prime(5)
y_prime(6)
y_prime(7)
y_prime(8)
end

=
=
=
=
=
=
=

-r_Ca*i_s+k_up*(Ca_SR - Ca);
alpha_x1*(1-x1) - beta_x1*x1;
alpha_m*(1-m) - beta_m*m;
alpha_h*(1-h) - beta_h*h;
alpha_j*(1-j) - beta_j*j;
alpha_d*(1-d) - beta_d*d;
alpha_f*(1-f) - beta_f*f;
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APPENDIX B

Three-Dimensional Model Combining the Beeler-Reuter and Bidomain Models

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%
%
%
Script:
BRBdiomain
%
%
Revision Date: 12/29/2020
%
%
Author:
Julia Kelley
%
%
Script for creating a 3D model of cardiac tissue by integrating the
%
Bidomain and Beeler Reuter Models.
%
Uses the BR_Prime function file as the basis of the Beeler_Retuer
model.
%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%
close all
clear all
% Tissue Grid
Tx = 10;
Ty = 10;
Tz = 5;
TS = Tx*Ty*Tz;
ht = .2e-3;
(m)

%
%
%
%
%

number of nodes in the x direction
number of nodes in the y direction
number of nodes in the z direction
total tissue size
distance between tissue grid points

% Bath grid (on two sides of tissue)
Bx = Tx;
% number of nodes in the x direction
By = Ty;
% number of nodes in the y direction
Bz = 10;
% number of nodes in the z direction
BS = Bx*By*Bz;
% total bath size
hb = 0.2E-3;
% distance between bath grid points (m)
% Time Steps
t_simulation = 3;
delta_t = 0.02;
N = t_simulation/delta_t;

% simulation time (ms)
% size of time step (ms)
% number of time steps (dimensionless)

fprintf('Set up stimulus\n')
% Stimulus
Stimulus = 3E5;
t_stim_on = 5;
t_stim = 1;
t_stim_on = t_stim_on/delta_t;
t_stim = t_stim/delta_t;
% Stimulus point number
P = 1;
(0,0,0)
Istim = zeros(TS,1);

%
%
%
%
%

stimulus current (mA/m^2)
start of stimulus (ms)
stimulus duration (ms)
(dimensionless)
(dimensionless)

% Stimulate at corner point location =
% units [mA/m^2]
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Istim(P,1) = Stimulus;
% Membrane parameter
beta = 3E5;
% Conductivity
sigmax_i = 0.2;
sigmay_i = 0.02;
fiber
sigmaz_i = 0.02;
fiber

% surface to volume ratio (1/m)
% intracellular conductance along fiber
(x dir.) (S/m)
% intracellular conductance vertical to
(y dir.) (S/m)
% intracellular conductance vertical to
(z dir.) (S/m)

sigmax_e = 0.2;
sigmay_e = 0.08;
fiber
sigmaz_e = 0.08;
fiber

% extracellular conductance along fiber
(x dir.) (S/m)
% extracellular conductance vertical to
(y dir.) (S/m)
% extracellular conductance vertical to
(z dir.) (S/m)

sigmax_b = 0.2;
sigmay_b = 0.2;
sigmaz_b = 0.2;

% bath conductance in x direction (S/m)
% bath conductance in y direction (S/m)
% bath conductance in z direction (S/m)

% Laplacian matrices used to solve finite difference method (spatial
discretization)
% Boundary conditions are included in the matrices
fprintf('Laplacian matrix\n')
% Laplacian matrix for sigma_i in tissue and bath
BigM_i = spalloc(TS+2*BS,TS+2*BS,2*Tx*Ty+2*(Ty-2)*(Tz-2)+6*(Tx-2)*(Ty2)*(Tz-2)+2*BS); % units: [dimensionless]
for n = 1:BS
BigM_i(n,n) = 1;
end
for n = BS+1:BS+TS
BigM_i(n,n) = 1;
if n < BS+Tx*Ty+1
for k = 1:Ty-2
if n > BS+k*Tx+1 && n < BS + (k+1)*Tx
BigM_i(n,n) = (-2*sigmax_i - 2*sigmay_i)/ht^2; % units
= [S/m^3] defines the conductivity at each node point
BigM_i(n,n-1) = sigmax_i/ht^2; % Defines the
conductivity at each point in the intracellular domain in the x
direction
BigM_i(n,n+1) = sigmax_i/ht^2;
BigM_i(n,n-Tx) = sigmay_i/ht^2; % Defines the
conductivity at each point in the intracellular domain in the y
direction
BigM_i(n,n+Tx) = sigmay_i/ht^2;
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end
end
end
for kk = 1:Tz-2
for k = 1:Ty-2
if ((n > BS+kk*Tx*Ty+k*Tx+1) && (n < BS+kk*Tx*Ty+(k+1)*Tx))
BigM_i(n,n) = (-2*sigmax_i-2*sigmay_i-2*sigmaz_i)/ht^2;
BigM_i(n,n-1) = sigmax_i/ht^2;
BigM_i(n,n+1) = sigmax_i/ht^2;
BigM_i(n,n-Tx) = sigmay_i/ht^2;
BigM_i(n,n+Tx) = sigmay_i/ht^2;
BigM_i(n,n-Tx*Ty) = sigmaz_i/ht^2;
BigM_i(n,n+Tx*Ty) = sigmaz_i/ht^2;
end
end
end
end
for n = BS+TS:TS+2*BS
BigM_i(n,n) = 1;
end
% Laplacian matrix for sigma e in tissue
M_e = spalloc(TS,TS,2*Tx*Ty+2*(Ty-2)*(Tz-2)+6*(Tx-2)*(Ty-2)*(Tz-2));
for n = 1:TS
M_e(n,n) = 1;
if n < Tx*Ty+1
for k = 1:Ty-2
if n > k*Tx+1 && n < (k+1)*Tx
M_e(n,n) = (-2*sigmax_e - 2*sigmay_e)/ht^2;
M_e(n,n-1) = sigmax_e/ht^2;
M_e(n,n+1) = sigmax_e/ht^2;
M_e(n,n-Tx) = sigmay_e/ht^2;
M_e(n,n+Tx) = sigmay_e/ht^2;
end
end
end
for kk = 1:Tz-2
for k = 1:Ty-2
if ((n > kk*Tx*Ty+k*Tx+1) && (n < kk*Tx*Ty+(k+1)*Tx))
M_e(n,n) = (-2*sigmax_e-2*sigmay_e-2*sigmaz_e)/ht^2;
M_e(n,n-1) = sigmax_e/ht^2;
M_e(n,n+1) = sigmax_e/ht^2;
M_e(n,n-Tx) = sigmay_e/ht^2;
M_e(n,n+Tx) = sigmay_e/ht^2;
M_e(n,n-Tx*Ty) = sigmaz_e/ht^2;
M_e(n,n+Tx*Ty) = sigmaz_e/ht^2;
end
end
end
end
% Laplacian Matrix for (sigma_i + sigma_e) in tissue and bath
BigM_ie = spalloc(TS+2*BS,TS+2*BS,2*Tx*Ty+2*(Ty-2)*(Tz-2)+6*(Tx2)*(Ty-2)*(Tz-2)+2*BS+12*(Bx-2)*(By-2)*(Bz-2));
for n = 1:BS
BigM_ie(n,n) = 1;
for kk = 1:Bz-2
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for k = 1:By-2
if ((n > kk*Bx*By+k*Bx+1) && (n < kk*Bx*By + (k+1)*Bx))
BigM_ie(n,n) = (-2*sigmax_b-2*sigmay_b-2*sigmaz_b)/hb^2;
BigM_ie(n,n-1) = sigmax_b/hb^2;
BigM_ie(n,n+1) = sigmax_b/hb^2;
BigM_ie(n,n-Bx) = sigmay_b/hb^2;
BigM_ie(n,n+Bx) = sigmay_b/hb^2;
BigM_ie(n,n-Bx*By) = sigmaz_b/hb^2;
BigM_ie(n,n+Bx*By) = sigmaz_b/hb^2;
end
end
end
end
for n = BS+1:BS+TS
BigM_ie(n,n) = 1;
if n < BS+Tx*Ty+1
for k = 1:Ty-2
if n > BS+k*Tx+1 && n < BS+(k+1)*Tx
BigM_ie(n,n) = (-(sigmax_e+sigmax_b)-(sigmay_e+sigmay_b)sigmaz_e-sigmaz_b)/ht^2;
BigM_ie(n,n-1) = (sigmax_e+sigmax_b)/2*ht^2;
BigM_ie(n,n+1) = (sigmax_e+sigmax_b)/2*ht^2;
BigM_ie(n,n-Tx) = (sigmay_e+sigmay_b)/2*ht^2;
BigM_ie(n,n+Tx) = (sigmay_e+sigmay_b)/2*ht^2;
BigM_ie(n,n-Tx*Ty) = sigmaz_b/hb^2;
BigM_ie(n,n+Tx*Ty) = sigmaz_e/ht^2;
end
end
end
for kk = 1:Tz-2
for k = 1:Ty-2
if ((n > BS+kk*Tx*Ty+k*Tx+1) && (n <
BS+kk*Tx*Ty+(k+1)*Tx))
BigM_ie(n,n) = (-2*(sigmax_i+sigmax_e)2*(sigmay_i+sigmay_e)-2*(sigmaz_i+sigmaz_e))/ht^2;
BigM_ie(n,n-1) = (sigmax_i+sigmax_e)/ht^2;
BigM_ie(n,n+1) = (sigmax_i+sigmax_e)/ht^2;
BigM_ie(n,n-Tx) = (sigmay_i+sigmay_e)/ht^2;
BigM_ie(n,n+Tx) = (sigmay_i+sigmay_e)/ht^2;
BigM_ie(n,n-Tx*Ty) = (sigmaz_i+sigmaz_e)/ht^2;
BigM_ie(n,n+Tx*Ty) = (sigmaz_i+sigmaz_e)/ht^2;
end
end
end
if n > BS+Tx*Ty*(Tz-1)
BigM_ie(n,n) = (-(sigmax_e+sigmax_b)-(sigmay_e+sigmay_b)(sigmaz_e+sigmaz_b))/ht^2;
BigM_ie(n,n-1) = (sigmax_e+sigmax_b)/2*ht^2;
BigM_ie(n,n+1) = (sigmax_e+sigmax_b)/2*ht^2;
BigM_ie(n,n-Tx) = (sigmay_e+sigmay_b)/2*ht^2;
BigM_ie(n,n+Tx) = (sigmay_e+sigmay_b)/2*ht^2;
BigM_ie(n,n-Tx*Ty) = sigmaz_e/ht^2;
BigM_ie(n,n+Tx*Ty) = sigmaz_b/hb^2;
end
end
for n = BS+TS+1:TS+2*BS
BigM_ie(n,n) = 1;
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for kk = 1:Bz-2
for k = 1:By-2
if ((n > BS+TS+(kk-1)*Bx*By+k*Bx+1) && (n < BS+TS+(kk1)*Bx*By+(k+1)*Bx))
BigM_ie(n,n) = (-2*sigmax_b-2*sigmay_b-2*sigmaz_b)/hb^2;
BigM_ie(n,n-1) = sigmax_b/hb^2;
BigM_ie(n,n+1) = sigmax_b/hb^2;
BigM_ie(n,n-Bx) = sigmay_b/hb^2;
BigM_ie(n,n+Bx) = sigmay_b/hb^2;
BigM_ie(n,n-Bx*By) = sigmaz_b/hb^2;
BigM_ie(n,n+Bx*By) = sigmaz_b/hb^2;
end
end
end
end
neg_BigM_ie = -BigM_ie;
(positive definiteness)

% makes bicgstabl function applicable

fprintf('Beeler Reuter parameters\n')
global Cm r_Ca Ca_SR k_up A_K1 A_x1 g_Na g_NaC V_Na g_s A_s t_on
t_dur;
Cm = 1;
r_Ca = 1E-7;
Ca_SR = 1E-7;
k_up = 0.07;
A_K1 = 0.35;
A_x1 = 0.8;
V_Na = 50;
g_Na = 4;
g_NaC = 0.003;
g_s = 0.09;
A_s = 40;
t_on = 50;
t_dur = 1;

%
%
%
%
%
%
%
%
%
%
%
%
%

uC/cm^23
M*cm^2/nC
M
1/ms
uA/cm^2
uA/cm^2
mV
mS/cm^2
mS/cm^2
mS/cm^2
uA/cm^2
ms
ms

Y_initial = [-83.3, 1.87E-7, 0.1644, 0.01, 0.9814, 0.9673, 0.0033,
0.9884];
options = odeset('MaxStep', 1.05);
[time, Y_out] = ode15s('BR_Prime', [0 499], Y_initial, options);
membrane_potential = Y_out(:,1);
Vhelp = zeros(TS+2*BS,1);
Vhelp(BS+1:BS+TS) = membrane_potential;
phi_e = zeros(TS,N);
Big_phi = zeros(TS+2*BS,1);
neg_Big_phi = -Big_phi;
fprintf('Bidomain solution\n')
for i = 1:N-1
[neg_Big_phi(:,1),flag] = bicgstabl(neg_BigM_ie,(BigM_i*Vhelp));
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if flag
end
Big_phi(:,1) = -neg_Big_phi(:,1);
phi_e(:,1) = Big_phi(BS+1:BS+TS,1);
if i <= t_stim
dVmdt = (-M_e*phi_e(:,1)+Istim)/(beta*Cm)(membrane_potential(:,1));
else
dVmdt = (-M_e*phi_e(:,1))/(beta*Cm)(membrane_potential(:,1));
end
for kz = 1:Tz
dVmdt((kz-1)*Tx*Ty+1:(kz-1)*Tx*Ty+Tx+1,1) = 0;
dVmdt((kz-1)*Tx*Ty+(Ty-1)*Tx:(kz-1)*Tx*Ty+Tx*Ty,1) = 0;
for ky = 2:Ty-2
dVmdt((kz-1)*Tx*Ty+ky*Tx:(kz-1)*Tx*Ty+ky*Tx+1,1) = 0;
end
end
membrane_potential(:,i+1) =
membrane_potential(:,1)+dVmdt*(delta_t/1000);
Vhelp(BS+1:BS+TS) = membrane_potential(:,i+1);
end
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